Company Snapshot: Nemaura Medical Inc.

NMRD
Last	Change	Volume	High	Low

Company Overview

Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes specialty medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as for screening pre-diabetic patients. The company was founded in 2009 and is headquartered in Loughborough, the United Kingdom.

Client News

1. Oct 5 2021 Nemaura Medical to Present at the LD Micro Main Event Conference
2. Sep 29 2021 Nemaura Medical Launches Beta Version of Its Metabolic Health Program
3. Sep 27 2021 Nemaura Medical Announces Commercial Agreement with UK Licensee
4. Sep 24 2021 Nemaura Medical Inc. (NASDAQ: NMRD) Diabetes, Obesity Solutions Differentiated in Form and Function